Apellis Pharmaceuticals

/Apellis Pharmaceuticals

They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.

Symbol

Price Range
TBD

Anticipated Shares
10,000,000

Effective Date
November 9, 2017

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange